Influenza vaccine: progress in a vaccine that elicits a broad immune response.

Irina Isakova-SivakEkaterina StepanovaDaria MezhenskayaVictoria MatyushenkoPolina ProkopenkoIvan SychevPei-Fong WongLarisa Rudenko

Published in: Expert review of vaccines (2021)

cHA: chimeric HA; HBc: hepatitis B virus core protein; HA: hemagglutinin; HLA: human leucocyte antigen; IIV: inactivated influenza vaccine; KLH: keyhole limpet hemocyanin; LAH: long alpha helix; LAIV: live attenuated influenza vaccine; M2e: extracellular domain of matrix 2 protein; MHC: major histocompatibility complex; mRNA: messenger ribonucleic acid; NA: neuraminidase; NS1: non-structural protein 1; qNIV: quadrivalent nanoparticle influenza vaccine; TRM: tissue-resident memory T cells; VE: vaccine effectiveness; VLP: virus-like particles; VSV: vesicular stomatitis virus.

Keyphrases

hepatitis b virus
immune response
protein protein
binding protein
endothelial cells
randomized controlled trial
amino acid
systematic review
liver failure
stem cells
cell therapy
dendritic cells
mesenchymal stem cells
induced pluripotent stem cells
transcription factor